Starts 02/02/2026 | Expires 12/31/2026
Didn't make it to the AACE 2025 Clinical Guidance Forum? Explore the newest AACE clinical guidance documents presented by the experts who created them and earn up to 5 CME/CE/MOC credits. This on-demand resource offers practical, case-based learning to help you implement evidence-based care in obesity, dyslipidemia, multiple endocrine neoplasia type 1, and menopause management.
By the end of this conference, participants will be able to:
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Endocrinology (ACE) designates this enduring activity for a maximum of 5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit. Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared.
The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.
Ricardo Correa, MD, EdD, FACP, FACE, FACMQ
Academy of Physician for Clinical ResearchMaricopa County Medical SocietyArizona Medical AssociationCECP ACP Governing CouncilAMA IMG Governing CouncilModerna
ConsultantConsultantConsultantConsultantConsultantVaccines Study
Joanna Miragaya, MD, PhD, FACE
None
All of the relevant financial relationships listed for these individuals have been mitigated. All other planners for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
None of the reviewers for this educational activity have any relevant financial relationships with ineligible companies to disclose.
Osteoporosis is a chronic disease that requires timely diagnosis, early intervention, and long-term management to reduce fracture risk and support lifelong skeletal health. This online course is designed for endocrinologists, primary care physicians, nurse practitioners, physician assistants, and other healthcare professionals who care for patients with osteoporosis. Unlock the skills and knowledge needed to effectively diagnose, treat, and manage osteoporosis. With a focus on long-term care strategies, you will gain practical tools to reduce fracture risk and improve patient outcomes. The course also explores the epidemiology of osteoporosis and fractures in men, while building an understanding of the key differences in skeletal health evaluation between men and women. Gather strategies to improve patient adherence in osteoporosis while enhancing monitoring and follow-up practices to assess treatment efficacy and support better patient outcomes.
Starts 6/17/2026 | Expires 6/17/2027
Starts: May 29, 2026 Expires: May 29, 2028
Didn't make it to the AACE 2026 Annual Meeting? You can still access all the invaluable insights and groundbreaking discoveries with our on-demand session recordings. Gain newfound knowledge to improve patient outcomes, assess the potential applications of emerging scientific advances, and earn up to 47.25 CME/CE/MOC credits for eligible recorded sessions. Don't miss this opportunity to elevate your practice and professional growth—register now and experience the transformative content from AACE 2026 at your own pace.
Starts 6/01/2026 | Expires 4/30/2027
Starts 12/15/2025 | Expires12/15/2027Osteoporosis and osteopenia are chronic conditions that significantly increase the risk of fractures both in the United States and globally. Effective management requires healthcare professionals to understand bone metabolism and the physiological changes that contribute to bone loss.
The Kidney in Cardiometabolic Disease session presented at the AACE 2025 Annual Meeting highlights the critical role of kidney function in managing cardiometabolic disorders, such as diabetes, heart failure, and cardiovascular diseases, emphasizing the importance of integrated care approaches through a case-based interactive program format.
The session aims to deepen understanding of how renal dysfunction can influence the progression and management of cardiometabolic diseases, with an emphasis on:
• The pathophysiology of chronic kidney disease within the cardiometabolic spectrum, including age-related changes and mineral-bone disorders.• The impact of renal impairment on cardiovascular risk and metabolic control.• Strategies for early detection and management of renal complications in cardiometabolic patients, including risk assessment considerations for aging populations with declining renal function
Starts 9/3/2025 | Expires 9/3/2027Dyslipidemia is a major contributor to cardiovascular disease, yet many patients remain undermanaged due to evolving guidelines and care complexities. This program addresses these gaps, helping clinicians optimize lipid management and improve cardiovascular outcomes.